share_log

Abbisko to Publish Results of Tenosynovial Tumor Medication Phase 1B Trial at Meeting in Canada

Abbisko to Publish Results of Tenosynovial Tumor Medication Phase 1B Trial at Meeting in Canada

阿比斯科將在加拿大的會議上公佈腱滑膜腫瘤藥物1B期試驗的結果
MT Newswires ·  2022/11/15 01:32

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論